Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice.

[1]  Akihiro Umezawa,et al.  Can the life span of human marrow stromal cells be prolonged by bmi‐1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation? , 2004, The journal of gene medicine.

[2]  M. Goodell,et al.  Skeletal Muscle Fiber‐Specific Green Autofluorescence: Potential for Stem Cell Engraftment Artifacts , 2004, Stem cells.

[3]  C. Mummery,et al.  A P19Cl6 GFP reporter line to quantify cardiomyocyte differentiation of stem cells. , 2004, The International journal of developmental biology.

[4]  P. Zandstra,et al.  Scalable production of embryonic stem cell-derived cardiomyocytes. , 2003, Tissue engineering.

[5]  Jürgen Hescheler,et al.  Cardiac specific differentiation of mouse embryonic stem cells. , 2003, Cardiovascular research.

[6]  E. Willbold,et al.  Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies. , 2003, Cytotherapy.

[7]  C. Murry,et al.  Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. , 2002, Journal of molecular and cellular cardiology.

[8]  S. Ogawa,et al.  Bone Marrow–Derived Regenerated Cardiomyocytes (CMG Cells) Express Functional Adrenergic and Muscarinic Receptors , 2002, Circulation.

[9]  G. Cossu,et al.  Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Entman,et al.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. , 2001, The Journal of clinical investigation.

[11]  K Walsh,et al.  Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. , 2001, Journal of molecular and cellular cardiology.

[12]  E. Olson,et al.  MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells. , 2001, Developmental biology.

[13]  I. Weissman,et al.  Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. , 2001, Annual review of cell and developmental biology.

[14]  A M Wobus,et al.  Selection of ventricular‐like cardiomyocytes from ES cells in vitro , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  I. Weissman,et al.  Translating stem and progenitor cell biology to the clinic: barriers and opportunities. , 2000, Science.

[16]  R. Weisel,et al.  Autologous heart cell transplantation improves cardiac function after myocardial injury. , 1999, The Annals of thoracic surgery.

[17]  S. Masuda,et al.  Formation of cell junctions between grafted and host cardiomyocytes at the border zone of rat myocardial infarction. , 1999, Circulation.

[18]  R. Weisel,et al.  Autologous transplantation of bone marrow cells improves damaged heart function. , 1999, Circulation.

[19]  L. Daviet,et al.  AT2 receptor and vascular smooth muscle cell differentiation in vascular development. , 1999, Hypertension.

[20]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[21]  B. Fleischmann,et al.  Functional Characteristics of ES Cell–derived Cardiac Precursor Cells Identified by Tissue-specific Expression of the Green Fluorescent Protein , 1998, The Journal of cell biology.

[22]  K. Fukuda,et al.  Angiotensin II potentiates DNA synthesis in AT-1 transformed cardiomyocytes. , 1998, Journal of molecular and cellular cardiology.

[23]  L. Kedes,et al.  Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? , 1996, Circulation.

[24]  G. Koh,et al.  Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. , 1996, The Journal of clinical investigation.

[25]  Y. Kanegae,et al.  A simple and efficient method for purification of infectious recombinant adenovirus. , 1994, Japanese journal of medical science & biology.

[26]  K. Chien,et al.  Positional specification of ventricular myosin light chain 2 expression in the primitive murine heart tube. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[28]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[29]  K. Chien,et al.  Structure, organization, and expression of the rat cardiac myosin light chain-2 gene. Identification of a 250-base pair fragment which confers cardiac-specific expression. , 1989, The Journal of biological chemistry.